FibroGen, Inc. (FGEN) on Thursday announced that it will implement a 1-for-25 reverse stock split of its issued and outstanding common stock, effective June 16, 2025.
FibroGen's common stock will begin trading on a split-adjusted basis on June 17, 2025, when the markets open, under the company's existing trading symbol "FGEN."
The Reverse Stock Split was previously approved by stockholders at the company's annual meeting of stockholders held on June 4, 2025, with the final ratio determined by the Company's Board of Directors. One
At the effective time of the Reverse Stock Split, every 25 shares of the Company's issued and outstanding common stock will automatically be reclassified and combined into one share of the Company's common stock.
This will reduce the number of issued and outstanding shares of common stock from approximately 101.1 million shares to approximately 4.0 million shares.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.